Frequency, Mortality, and Predictors of Adverse Outcomes for Endocarditis in Patients with Congenital Heart Disease: Results of a Nationwide Analysis including 2512 Endocarditis Cases

Background: Infective endocarditis (IE) represents a major complication in patients with congenital heart disease (CHD) and is associated with high morbidity and mortality. The aim of this study was to analyse the frequency and outcome of IE in contemporary CHD patients based on all IE hospital admi...

Full description

Bibliographic Details
Main Authors: Maarja Maser, Eva Freisinger, Leo Bronstein, Jeanette Köppe, Stefan Orwat, Gerrit Kaleschke, Helmut Baumgartner, Gerhard-Paul Diller, Astrid Lammers
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/21/5071
_version_ 1797512329487712256
author Maarja Maser
Eva Freisinger
Leo Bronstein
Jeanette Köppe
Stefan Orwat
Gerrit Kaleschke
Helmut Baumgartner
Gerhard-Paul Diller
Astrid Lammers
author_facet Maarja Maser
Eva Freisinger
Leo Bronstein
Jeanette Köppe
Stefan Orwat
Gerrit Kaleschke
Helmut Baumgartner
Gerhard-Paul Diller
Astrid Lammers
author_sort Maarja Maser
collection DOAJ
description Background: Infective endocarditis (IE) represents a major complication in patients with congenital heart disease (CHD) and is associated with high morbidity and mortality. The aim of this study was to analyse the frequency and outcome of IE in contemporary CHD patients based on all IE hospital admissions in Germany over a 10-year period. Methods: Based on data of all hospital admissions in Germany from 2009 to 2018, we identified all CHD cases with a diagnosis of IE. The data contained information on patient demographics, diagnoses, surgical procedures, and mortality. The primary endpoint of the study was endocarditis-associated mortality as well as major adverse events (defined as death or myocardial infarction, stroke, pulmonary embolism, sepsis, renal dialysis, resuscitation, or intubation). Results: Overall, 309,245 CHD inpatient cases were included in the analysis (underlying heart defects of simple complexity 55%, moderate complexity 23%, and complex heart defects 22%, respectively). Of those, 2512 (0.8% of all inpatient cases) were treated for IE. The mortality rate of IE inpatient cases was 6% with a major adverse events rate of 46%, and 41.5% of cases required surgical intervention. The overall IE associated mortality was lower in adult CHD cases compared to the 153,242 in adult IE cases without CHD (7.1% vs. 16.1%, <i>p</i> < 0.001). After adjustments using multivariable logistic regression analysis, the presence or complexity of CHD was not associated with the outcomes. Meanwhile, age, male sex, and co-morbidities emerged as significant predictors of adverse outcomes. Conclusions: IE accounts for a minority of CHD related hospitalizations but remains a deadly disease, and major adverse events are common in this setting. Due to different demographic and co-morbidity spectrums, adult CHD patients tend to have better survival prospects when compared to non-CHD IE patients. Acquired co-morbidities emerged as the main predictors of adverse outcomes.
first_indexed 2024-03-10T05:59:18Z
format Article
id doaj.art-fe5919dd2807405fa062798151d9f150
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T05:59:18Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-fe5919dd2807405fa062798151d9f1502023-11-22T21:06:54ZengMDPI AGJournal of Clinical Medicine2077-03832021-10-011021507110.3390/jcm10215071Frequency, Mortality, and Predictors of Adverse Outcomes for Endocarditis in Patients with Congenital Heart Disease: Results of a Nationwide Analysis including 2512 Endocarditis CasesMaarja Maser0Eva Freisinger1Leo Bronstein2Jeanette Köppe3Stefan Orwat4Gerrit Kaleschke5Helmut Baumgartner6Gerhard-Paul Diller7Astrid Lammers8Department of Cardiology III-Adult Congenital and Valvular Heart Disease, University Hospital Muenster, 48149 Muenster, GermanyDepartment of Cardiology I-Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, 48149 Muenster, GermanyInstitute of Biostatistics and Clinical Research, University of Muenster, 48149 Muenster, GermanyInstitute of Biostatistics and Clinical Research, University of Muenster, 48149 Muenster, GermanyDepartment of Cardiology III-Adult Congenital and Valvular Heart Disease, University Hospital Muenster, 48149 Muenster, GermanyDepartment of Cardiology III-Adult Congenital and Valvular Heart Disease, University Hospital Muenster, 48149 Muenster, GermanyDepartment of Cardiology III-Adult Congenital and Valvular Heart Disease, University Hospital Muenster, 48149 Muenster, GermanyDepartment of Cardiology III-Adult Congenital and Valvular Heart Disease, University Hospital Muenster, 48149 Muenster, GermanyDepartment of Cardiology III-Adult Congenital and Valvular Heart Disease, University Hospital Muenster, 48149 Muenster, GermanyBackground: Infective endocarditis (IE) represents a major complication in patients with congenital heart disease (CHD) and is associated with high morbidity and mortality. The aim of this study was to analyse the frequency and outcome of IE in contemporary CHD patients based on all IE hospital admissions in Germany over a 10-year period. Methods: Based on data of all hospital admissions in Germany from 2009 to 2018, we identified all CHD cases with a diagnosis of IE. The data contained information on patient demographics, diagnoses, surgical procedures, and mortality. The primary endpoint of the study was endocarditis-associated mortality as well as major adverse events (defined as death or myocardial infarction, stroke, pulmonary embolism, sepsis, renal dialysis, resuscitation, or intubation). Results: Overall, 309,245 CHD inpatient cases were included in the analysis (underlying heart defects of simple complexity 55%, moderate complexity 23%, and complex heart defects 22%, respectively). Of those, 2512 (0.8% of all inpatient cases) were treated for IE. The mortality rate of IE inpatient cases was 6% with a major adverse events rate of 46%, and 41.5% of cases required surgical intervention. The overall IE associated mortality was lower in adult CHD cases compared to the 153,242 in adult IE cases without CHD (7.1% vs. 16.1%, <i>p</i> < 0.001). After adjustments using multivariable logistic regression analysis, the presence or complexity of CHD was not associated with the outcomes. Meanwhile, age, male sex, and co-morbidities emerged as significant predictors of adverse outcomes. Conclusions: IE accounts for a minority of CHD related hospitalizations but remains a deadly disease, and major adverse events are common in this setting. Due to different demographic and co-morbidity spectrums, adult CHD patients tend to have better survival prospects when compared to non-CHD IE patients. Acquired co-morbidities emerged as the main predictors of adverse outcomes.https://www.mdpi.com/2077-0383/10/21/5071congenital heart diseaseinfective endocarditisoutcomesmortality
spellingShingle Maarja Maser
Eva Freisinger
Leo Bronstein
Jeanette Köppe
Stefan Orwat
Gerrit Kaleschke
Helmut Baumgartner
Gerhard-Paul Diller
Astrid Lammers
Frequency, Mortality, and Predictors of Adverse Outcomes for Endocarditis in Patients with Congenital Heart Disease: Results of a Nationwide Analysis including 2512 Endocarditis Cases
Journal of Clinical Medicine
congenital heart disease
infective endocarditis
outcomes
mortality
title Frequency, Mortality, and Predictors of Adverse Outcomes for Endocarditis in Patients with Congenital Heart Disease: Results of a Nationwide Analysis including 2512 Endocarditis Cases
title_full Frequency, Mortality, and Predictors of Adverse Outcomes for Endocarditis in Patients with Congenital Heart Disease: Results of a Nationwide Analysis including 2512 Endocarditis Cases
title_fullStr Frequency, Mortality, and Predictors of Adverse Outcomes for Endocarditis in Patients with Congenital Heart Disease: Results of a Nationwide Analysis including 2512 Endocarditis Cases
title_full_unstemmed Frequency, Mortality, and Predictors of Adverse Outcomes for Endocarditis in Patients with Congenital Heart Disease: Results of a Nationwide Analysis including 2512 Endocarditis Cases
title_short Frequency, Mortality, and Predictors of Adverse Outcomes for Endocarditis in Patients with Congenital Heart Disease: Results of a Nationwide Analysis including 2512 Endocarditis Cases
title_sort frequency mortality and predictors of adverse outcomes for endocarditis in patients with congenital heart disease results of a nationwide analysis including 2512 endocarditis cases
topic congenital heart disease
infective endocarditis
outcomes
mortality
url https://www.mdpi.com/2077-0383/10/21/5071
work_keys_str_mv AT maarjamaser frequencymortalityandpredictorsofadverseoutcomesforendocarditisinpatientswithcongenitalheartdiseaseresultsofanationwideanalysisincluding2512endocarditiscases
AT evafreisinger frequencymortalityandpredictorsofadverseoutcomesforendocarditisinpatientswithcongenitalheartdiseaseresultsofanationwideanalysisincluding2512endocarditiscases
AT leobronstein frequencymortalityandpredictorsofadverseoutcomesforendocarditisinpatientswithcongenitalheartdiseaseresultsofanationwideanalysisincluding2512endocarditiscases
AT jeanettekoppe frequencymortalityandpredictorsofadverseoutcomesforendocarditisinpatientswithcongenitalheartdiseaseresultsofanationwideanalysisincluding2512endocarditiscases
AT stefanorwat frequencymortalityandpredictorsofadverseoutcomesforendocarditisinpatientswithcongenitalheartdiseaseresultsofanationwideanalysisincluding2512endocarditiscases
AT gerritkaleschke frequencymortalityandpredictorsofadverseoutcomesforendocarditisinpatientswithcongenitalheartdiseaseresultsofanationwideanalysisincluding2512endocarditiscases
AT helmutbaumgartner frequencymortalityandpredictorsofadverseoutcomesforendocarditisinpatientswithcongenitalheartdiseaseresultsofanationwideanalysisincluding2512endocarditiscases
AT gerhardpauldiller frequencymortalityandpredictorsofadverseoutcomesforendocarditisinpatientswithcongenitalheartdiseaseresultsofanationwideanalysisincluding2512endocarditiscases
AT astridlammers frequencymortalityandpredictorsofadverseoutcomesforendocarditisinpatientswithcongenitalheartdiseaseresultsofanationwideanalysisincluding2512endocarditiscases